Leading the way inbiointerventional ophthalmic surgery
Redefining Expectations
Breakthrough Glaucoma Surgical Technologies
Iantrek is dedicated to meaningful innovation and developing next-generation technologies for total-outflow enhancement
What’s next in microinterventional ophthalmic surgery Find Out
The CycloPen™ Microinterventional Cyclodialysis System is ergonomically designed for the controlled creation or modification of a cyclodialysis.
The first of its kind, AlloFlo™ is a Bio-Interventional solution designed to naturally enhance uveo-scleral outflow through precision scleral reinforcement.
The C-Rex™ is transforming goniotomy with an elegant design that is fully circumferential, excisional, and titratable.
Innovation at our core
Iantrek is a company dedicated to meaningful innovation, founded by ophthalmic innovator Sean Ianchulev, MD MPH, Professor of Ophthalmology at New York Eye and Ear of Mount Sinai.
Testimonials
Watch testimonials
We asked ophthalmology thought leaders to share their experiences and thoughts on the CycloPen System - with AlloFlo Carriers.
This groundbreaking solution enhances uveoscleral outflow by using homologous bio-tissue for endoscleral reinforcement following the creation of a controlled cyclodialysis.
Dr. Robert Weinreb
Chairman and Director
Shiley Eye Institute
We are back to the future ...in the uveoscleral space! Iantrek’s micro-interventional technology opens new horizons in interventional glaucoma. Cyclodialysis creation, durable cleft maintenance and high-precision bio-tissue trephination in a hardware-free surgical approach can be a game-changer.
Dr. Tyson
Tyson Eye Center
Micro-interventional nitinol instrumentation offers new opportunities for the anterior segment surgery. The C-Rex and CycloPen System with AlloFlo Carriers allow surgeons unprecedented interventional access and control.
Dr. Ike Ahmed
Chief Medical Officer
The CycloPen System offers unprecedented ease of use and access to the uveoscleral space. Cyclodialysis cleft formation and reinforcement is precise, controlled and atraumatic.
Dr. Chang
Advisor, Past President of ASCRS
Ianrek has developed a best-in-class micro-interventional system for a dual-outflow MIGS surgery.
Board of Directors
Dr. Sean Ianchulev
Chairman of the Board
Professor NYEE
CMO
Adam Szaronos
Board Member
CEO
Jim Mazzo
Board Member
Neurotech
Dr. Stephen Bloch
Observer
Partner Canaan
Jeffry Weinhuff
Board Member
Partner Visionary Ventures
Andrew Corley
Observer
Co-Founder of
Flying-L Partners
Dr. Robert Weinreb
Board Member
Shiley Eye Institute
Dr. Toby Tyson
Board Member
Tyson Eye Center
Marc-André Marcotte
Board Member
Sectoral Asset Management
Partner & Chief Operating Officer
